Camlin Fine Sciences Ltd
CAMLINFINECamlin Fine Sciences Ltd
CAMLINFINE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -9.19 | 2.39 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 31.17 | 3.55 | 1.31% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Camlin Fine Sciences Limited is engaged in fine chemicals business. It provides antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions various industries.
Investor Presentation
View olderPeers
Compare with peersGujarat Fluorochemicals Ltd
Vinati Organics Ltd
Navin Fluorine International Ltd
Akzo Nobel India Ltd
Aarti Industries Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 493.61 | 548.46 | 732.33 | 905.96 | 1,052.58 | 1,192.08 | 1,445.12 | 1,687.36 | 1,628.62 | 1,628.30 | ||||||||||
Raw Materials | 250.26 | 294.26 | 424.79 | 495.45 | 553.17 | 566.17 | 772.90 | 916.28 | 860.87 | 1,735.80 | ||||||||||
| Power & Fuel Cost | 47.43 | 46.35 | 61.43 | 80.42 | 76.38 | 84.16 | 123.01 | 204.60 | 124.31 | |||||||||||
| Employee Cost | 40.05 | 61.09 | 72.87 | 87.89 | 99.71 | 120.38 | 145.05 | 162.62 | 178.75 | |||||||||||
| Selling & Administrative Expenses | 52.79 | 71.76 | 76.34 | 82.78 | 96.14 | 92.18 | 82.94 | 96.58 | 93.35 | |||||||||||
| Operating & Other expenses | 11.56 | 28.63 | 69.17 | 72.78 | 88.54 | 137.33 | 130.48 | 98.15 | 322.01 | |||||||||||
EBITDA | 91.52 | 46.37 | 27.73 | 86.64 | 138.64 | 191.86 | 190.74 | 209.13 | 49.33 | -107.50 | ||||||||||
| Depreciation/Amortization | 17.06 | 21.80 | 26.65 | 28.99 | 32.80 | 44.29 | 55.96 | 62.51 | 78.61 | 81.43 | ||||||||||
| PBIT | 74.46 | 24.57 | 1.08 | 57.65 | 105.84 | 147.57 | 134.78 | 146.62 | -29.28 | -188.93 | ||||||||||
| Interest & Other Items | 24.44 | 30.58 | 31.80 | 40.95 | 47.63 | 42.48 | 40.80 | 66.24 | 69.97 | 80.10 | ||||||||||
| PBT | 50.02 | -6.01 | -30.72 | 16.70 | 58.21 | 105.09 | 93.98 | 80.38 | -99.25 | -269.03 | ||||||||||
| Taxes & Other Items | 14.20 | 5.16 | -1.09 | 16.12 | 27.88 | 54.13 | 33.29 | 28.27 | -6.49 | -45.93 | ||||||||||
| Net Income | 35.82 | -11.17 | -29.63 | 0.58 | 30.33 | 50.96 | 60.69 | 52.11 | -92.76 | -223.10 | ||||||||||
| EPS | 3.72 | -1.11 | -2.63 | 0.05 | 2.50 | 4.10 | 4.27 | 3.32 | -5.72 | -13.32 | ||||||||||
| DPS | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Camlin Fine Sciences Ltd | -22.11 | 2.39 | — |
| Gujarat Fluorochemicals Ltd | 112.50 | 8.24 | 0.07% |
| Vinati Organics Ltd | 60.02 | 7.87 | 0.37% |
| Navin Fluorine International Ltd | 66.87 | 7.59 | 0.41% |
Price Comparison
Compare CAMLINFINE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.08%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Camlin Fine Sciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
ICICI Prudential Smallcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.5606% | Percentage of the fund’s portfolio invested in the stock 0.63% | Change in the portfolio weight of the stock over the last 3 months 0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/130 (+7) |
ICICI Prudential Commodities Fund - Cumulative - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6519% | Percentage of the fund’s portfolio invested in the stock 0.56% | Change in the portfolio weight of the stock over the last 3 months -0.38% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/56 (-8) |
ICICI Prudential Dividend Yield Equity Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1340% | Percentage of the fund’s portfolio invested in the stock 0.06% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 66/75 (-7) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CAMLINFINE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 28, 2016
Dividend/Share
₹0.45
Ex DateEx Date
Jul 28, 2016
Cash Dividend
Ex DateEx DateJul 27, 2015
Dividend/Share
₹0.45
Ex DateEx Date
Jul 27, 2015
Cash Dividend
Ex DateEx DateJul 24, 2014
Dividend/Share
₹0.70
Ex DateEx Date
Jul 24, 2014
Cash Dividend
Ex DateEx DateAug 1, 2013
Dividend/Share
₹0.60
Ex DateEx Date
Aug 1, 2013
Cash Dividend
Ex DateEx DateJul 23, 2012
Dividend/Share
₹0.50
Ex DateEx Date
Jul 23, 2012
The Board of Camlin Fine Sciences at its meeting held on 22 November 2024 has approved the following: - The revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crore; - The proposal for fund raising by way of issuance of up to 10,000 senior, secured, redeemable, unlisted, unrated, non-convertible debentures of face value of Rs. 100,000 each (NCDs) aggregating for an amount of Rs. 100 crore on a private placement basis. Powered by Capital Market - Live
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 22 November 2024Powered by Capital Market - Live
Net Loss of Camlin Fine Sciences reported to Rs 100.23 crore in the quarter ended September 2024 as against net loss of Rs 19.38 crore during the previous quarter ended September 2023. Sales rose 4.21% to Rs 422.97 crore in the quarter ended September 2024 as against Rs 405.88 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales422.97405.88 4 OPM %10.236.19 - PBDT29.427.12 313 PBT8.73-12.09 LP NP-100.23-19.38 -417 Powered by Capital Market - Live
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live
The Board of Camlin Fine Sciences at its meeting held on 10 September 2024 has approved the following: 1. Increase in authorised share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. 2. Raising of fund by way of issue of equity shares of the Company of face value Re 1 each through Rights Issue for an amount not exceeding Rs 150 crore. Powered by Capital Market - Live
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 10 September 2024.Powered by Capital Market - Live
Net loss of Camlin Fine Sciences reported to Rs 33.95 crore in the quarter ended June 2024 as against net profit of Rs 15.55 crore during the previous quarter ended June 2023. Sales declined 5.66% to Rs 395.85 crore in the quarter ended June 2024 as against Rs 419.60 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales395.85419.60 -6 OPM %4.589.23 - PBDT-3.3734.86 PL PBT-23.4816.08 PL NP-33.9515.55 PL Powered by Capital Market - Live
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Chennai Petroleum Corporation Ltd leads gainers in ‘A’ group
Camlin Fine Sciences rises for sixth day in row
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.45%, vs industry avg of 6.15%
Increasing Market Share
Over the last 5 years, market share increased from 1.64% to 1.92%